Cargando…
1366P Impact of COVID-19 on prostate cancer diagnosis and treatment
Autores principales: | Leszczynski, R.L., Norori, N., Beecroft, S., Wallace, J., Levick, B., Hobbs, M.D., Harding, T., Hall, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472514/ http://dx.doi.org/10.1016/j.annonc.2022.07.1498 |
Ejemplares similares
-
1366. Temporal changes in Demographics, Characteristics and Treatments for Patients enrolled in the Canadian Treatments for COVID-19 Trial
por: Mohsen, Samiha, et al.
Publicado: (2023) -
1366. Microbiology of Acute Hematogenous Osteomyelitis in Hospitalized Children
por: Hu, Nina, et al.
Publicado: (2020) -
1366. Re-examining the Origins of Ebola virus Emergence
por: Judson, Seth D
Publicado: (2022) -
1366. In Vitro and In Vivo Activity of Cefiderocol against Stenotrophomonas maltophilia Clinical Isolates
por: Ito, Akinobu, et al.
Publicado: (2018) -
P1366: NEW LYMPHOABLATIVE CONDITIONING REGIME FOR MULTIPLE SCLEROSIS – FIRST RESULTS FROM RUSSIAN PILOT STUDY
por: Rukavitcyn, A., et al.
Publicado: (2022)